TOP STORIES

• ORGANIZATION PI Forum to Make Proposals to Promote R&D, Make Pharmaceuticals Japan’s Key Industry: Chairman Toyoda
  August 9, 2012

• BUSINESS Daiichi Sankyo to Strengthen Cardiovascular Field by Comarketing Diabetes Treatments, Focusing on SGLT-2 Inhibitor
  August 8, 2012

• REGULATORY MOF Wants Generic Drug Share to Reach European, US Levels: Budget Examiner Shinkawa
  August 8, 2012

• BUSINESS 6 Listed Wholesalers Post Low Price Settlement Rates as of End-June, Showing Declines Compared to 2 Years Earlier
  August 7, 2012

• BUSINESS Astellas to “Seek Every Opportunity” for Domestic Vaccine Business, Including Alliances with Foreign Companies
  August 6, 2012

• BUSINESS DSP to Establish Sales Force for Anticancer Drugs in North America
  August 3, 2012

• BUSINESS Daiichi Sankyo: April-June Nexium Sales 6% of Full-Year Target, Set to Boost Promotion after Lifting of Long-Term Prescription Ban
  August 2, 2012

• REGULATORY Council Approves Economic Revitalization Strategy with Priority on 3 Sectors Including Life Science
  August 1, 2012

• BUSINESS Sanofi-aventis Reaches Settlement with Sawai, Takata Seiyaku in Allegra Patent Dispute; Allegra’s Use Patent Validity Established
  July 31, 2012

• REGULATORY MHLW to Use Senshin-iryo System to Develop Anticancer Drugs from FY2013
  July 30, 2012

• BUSINESS DPP-4 Inhibitor “Indispensable” to Strengthen Priority Field: Kyowa Kirin
  July 30, 2012

• BUSINESS Chugai Had Tough Start in Final Year of Midterm Plan: Chairman Nagayama
  July 30, 2012

• BUSINESS Takeda Initiates PIII Trial for Anticancer Agent Motesanib in Asia
  July 27, 2012

• ORGANIZATION EFPIA Submits Opinion Letter to MHLW Calling for Review of Priority Focus on Japanese Companies for Blood Plasma Products
  July 27, 2012

• BUSINESS Taiho Licenses Anti-Allergy Drug from Faes Farma in Japan
  July 26, 2012

• REGULATORY MHLW Asks Sanofi Pasteur to Consider Reducing Price of IPV
  July 25, 2012

• ORGANIZATION Hiroshima Wholesale FTC Sees “Gradual Effects” in Correcting Labor Services in Cooperation with Pharmacists
  July 25, 2012

• BUSINESS Confident of Posting Sales of 100 Billion Yen with 3 Focal Products Including Teribone: Asahi Kasei Pharma President Asano
  July 24, 2012

• BUSINESS HBM Taking Advantage of Avian Biotechnology for Antibody Drug Discovery: President Toyoura
  July 23, 2012

• BUSINESS Inlyta as Standard Drug in Second-Line Treatment: Pfizer
  July 20, 2012

ページ

• « 先頭
• ‹ Prev
• …
• 231
• 232
• 233
• 234
• 235
• 236
• 237
• 238
• 239
• …
• Next ›
• 最終 »